Literature DB >> 21435417

Treatment of community-acquired pneumonia in an ambulatory setting.

Saira Butt1, Edwin Swiatlo.   

Abstract

Community-acquired pneumonia continues to be a significant cause of morbidity and mortality despite broad-spectrum antibiotics and advances in critical care. Frequently, the diagnosis is confounded by coexisting cardiac or pulmonary conditions. Recognition of patients at risk for complications from pneumonia is critical when making the decision of how and where to treat. This review summarizes the diagnosis and treatment of community-acquired pneumonia with oral antibiotics in an outpatient setting. Specific pathogens and clinical presentations in certain at-risk populations are highlighted. Also presented are validated algorithms for evaluating and identifying patients who may be at risk for serious complications of pneumonia and require treatment in an inpatient setting. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21435417     DOI: 10.1016/j.amjmed.2010.06.027

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

1.  Combination antibiotic therapy for community-acquired pneumonia.

Authors:  Jesus Caballero; Jordi Rello
Journal:  Ann Intensive Care       Date:  2011-11-23       Impact factor: 6.925

2.  Presence and extent of the primary health care attributes among children hospitalized for pneumonia.

Authors:  Juliana Coelho Pina; Suzana Alves de Moraes; Maria Cândida de Carvalho Furtado; Débora Falleiros de Mello
Journal:  Rev Lat Am Enfermagem       Date:  2015 May-Jun

3.  Antibiotic combinations reduce Staphylococcus aureus clearance.

Authors:  Viktória Lázár; Olga Snitser; Daniel Barkan; Roy Kishony
Journal:  Nature       Date:  2022-10-05       Impact factor: 69.504

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.